Baylor Licensing Group Mission

The Baylor Licensing Group maximizes the impact of research at Baylor College of Medicine through commercial relationships that lead to agreements to support the development of new products and services that benefit patients and the public.

What We Do

Our Core Activity

Negotiate and execute agreements with commercial partners:

  • Exclusive and non-exclusive license agreements
  • Sponsored research agreements (SRAs)
  • Material transfer agreements (MTAs)
  • Confidential disclosure agreements (CDAs)

Other Activities

  • Evaluate technologies for commercial viability
  • Evaluate patentability; arrange for patent prosecution if needed - typically around novel therapeutics and devices
  • Market technologies to industry
  • Educate the Baylor research community about technology commercialization
  • Coordinate legal review and approval of agreements
  • Distribute license income and monitor licensee compliance
  • Communicate our results to the Baylor community and beyond
BLG by the Numbers

Metric

FY15

FY16

FY17

FY18 YTD

Disclosures Received

112

104

100

104

Licensing Transactions

58

53

43

33

New Patent Applications Filed

56

58

77

24

New Issued U.S. Patents

16

15

17

11

Licensing Revenue

$5,992,122

$19,444,397

$3,699,040

$2,055,064

Contracted Sponsored Research Agreement Revenue

$1,858,199

$25,855,330

$17,946,140

$8,745,105

Sponsored Research Agreements Executed

16

25

15

15

Service Agreement Revenue

$714,578

$411,844

$3,440,547

$1,694,704

Service Agreements Executed

13

13

14

16

Contracted Indirects: SRAs

Not tabulated

Not tabulated

$6,604,262

$1,290,829

Contracted Indirects: Service Agreements

Not tabulated

Not tabulated

$1,336,908

$516,074

Total Non-License Agreements Executed

1,586

1,470

1,456

1,091

Aggregate BLG Value to BCM

FY Specific Revenue

$8,564,899

$32,654,951

$13,606,122

$7,118,718